Pharmacokinetics and bioequivalence evaluation of three commercial tablet formulations of mefloquine when given in combination with dihydroartemisinin in patients with acute uncomplicated falciparum malaria-Reference-Cited by-同舟云学术

Pharmacokinetics and bioequivalence evaluation of three commercial tablet formulations of mefloquine when given in combination with dihydroartemisinin in patients with acute uncomplicated falciparum malaria

Published:2000-01-20 Issue:10 Volume:55 Page:743-748
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:
Short-container-title:European Journal of Clinical Pharmacology

Author:

Na-Bangchang K.,Karbwang J.,Palacios P. A. C.,Ubalee R.,Saengtertsilapachai S.,Wernsdorfer W. H.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s002280050008.pdf

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An update on pharmacogenetic factors influencing the metabolism and toxicity of artemisinin-based combination therapy in the treatment of malaria;Expert Opinion on Drug Metabolism & Toxicology;2022-01-02

2. Performance of the Minto model for the target-controlled infusion of remifentanil during cardiopulmonary bypass;Anaesthesia;2017-09-11

3. Pharmacokinetic interactions between artesunate-mefloquine and ritonavir-boosted lopinavir in healthy Thai adults;Malaria Journal;2015-10-09

4. Gender-specific distribution of mefloquine in the blood following the administration of therapeutic doses;Malaria Journal;2013-12

5. Investigation of the in vitro Gender-Specific Partitioning of Mefloquine in Malarial Infected Red Blood Cells and Plasma;The American Journal of Tropical Medicine and Hygiene;2013-10-09